Circadian Phase Adjustment and Improvement of Metabolic Control in Night Shift Workers
NCT02108353
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
46
Enrollment
OTHER
Sponsor class
Conditions
Sleep Disorders, Circadian Rhythm
Interventions
DRUG:
Melatonin 2mg
DRUG:
Placebo
Sponsor
Universitätsklinikum Hamburg-Eppendorf